Abbreviations used: P450s, cytochromes P450; P450BM3, cytochrome P450 BM3 from B. megaterium (CYP102A1); DTT, dthiothreitol; DMSO, dimethylsulfoxide; RMSD, root mean square deviation; TLC, thin layer chromatography.
INTRODUCTION
Cytochromes P450 are a superfamily, currently numbering more than 6000, of haem-thiolate monooxygenase enzymes, found in almost all forms of life, which catalyse the activation of molecular oxygen 1 and the addition of an atom of oxygen to their substrate. 2 There is considerable sequence diversity within the superfamily; those members whose structures have been determined share a common overall fold, while differing markedly in their active site architecture, leading to very diverse substrate specificity.
Members of the superfamily include both enzymes of high specificity involved in the biosynthesis of, for example, steroids (in mammals, insects, plants, fungi and bacteria 3; 4; 5; 6 ), and polyketide antibiotics, 4 and also 'de-toxifying' enzymes, including the well-known mammalian drug-metabolising P450s, 3 which have a broad substrate specificity, allowing them to metabolise a very wide range of compounds.
The bacterial cytochromes P450 CYP101 (P450cam) from Pseudomonas putida and CYP102A1
(P450BM3) from Bacillus megaterium have been extensively studied structurally and mechanistically.
7; 8;
9 They have also been used as the starting point for the construction of mutants with altered specificity for use in chemical synthesis, where the ability of P450s to insert an oxygen atom into an unactivated C−H bond has potentially valuable applications. P450BM3, identified as a fatty acid hydroxylase, 10; 11 is a 119kDa polypeptide which contains a P450 domain and a diflavin NADPH-cytochrome P450 reductase domain 11; 12 similar to that in the mammalian drug-metabolising mono-oxygenase system. Unlike most P450s, therefore, which require additional electron transfer proteins, P450BM3 is catalytically selfsufficient. Perhaps because of this, P450BM3 also has the highest catalytic activity of any P450 monooxygenase identified to date.
P450BM3 catalyses the hydroxylation of C12-C16 saturated fatty acids at the (ω-1), (ω-2) and (ω-3) positions. 10; 11 The crystal structure of the substrate-free form of the haem domain 13 reveals a long hydrophobic active site channel extending from the protein surface, where there are charged residues suitable for binding a carboxylate group, to the haem iron -a structure entirely consistent with the observed fatty acid hydroxylase activity. The crystal contains two molecules in the asymmetric unit, one with an open substrate access channel and one where it is slightly more 'closed'; the two molecules have different intermolecular contacts in the crystal, and it seems likely that in solution there is a dynamic equilibrium between these and perhaps additional conformations of the access channel. 13 In the crystal structures of the protein bound to the substrates palmitoleic acid 14 and N-palmitoylglycine 15 the protein is seen to have undergone a significant conformational change involving a displacement of the F and G helices. Studies of the A264E mutant have provided evidence to support the idea that these 'substratefree' and 'substrate-bound' conformations, which are quite distinct from the 'open' and 'closed' structures seen in the crystal structure of the free enzyme, coexist in equilibrium in solution in the absence of substrate. 16 However, in none of the available structures of substrate complexes is the fatty acid bound with the (ω-1), (ω-2) and/or (ω-3) carbons positioned close to the iron in a position for hydroxylation. Instead, the 'ω end' of the fatty acid becomes sequestered in a hydrophobic pocket between phenylalanines 81 and 87, created by rotation of the aromatic ring of phenylalanine 87 by ~90º
and a rearrangement of nearby side-chains (notably isoleucine 263 and leucine 437), with its terminal methyl group in contact with alanine 82. In this position, the ω to ω-6 carbons of the fatty acid are all between 7.5Å and 10Å from the iron centre, too distant for hydroxylation. (Binding of substrates remote from the haem has also been observed in crystal structures of a number of eukaryotic P450s, e.g. 17; 18; 19 .)
All the available crystal structures of P450 BM3 thus represent inactive states of the enzyme-substrate complexes. This is in sharp contrast to P450cam, P450eryF and P450epoK, 20; 21; 22; 23 where the natural substrates are bound such that the sites of hydroxylation are positioned within 5Å of the iron, and little or no rearrangement is observed relative to the substrate-free form. NMR relaxation experiments 24 suggested that laurate and 12-bromo-laurate bind to P450BM3 in solution at room temperature in a similar way to that seen for palmitate in the crystal structures. However, recent evidence from solid-state NMR for differences in the environment of some active site residues, including Phe81 and Phe87, in the N-palmitoylglycine complex of P450BM3 between room temperature and −30°C, led to the suggestion, 25; 26 supported by molecular dynamics simulations, 27 that this may reflect an equilibrium between a low temperature binding mode which is seen in the crystal, and a different mode of binding at room temperature. It remains to be established whether the mode of binding seen in the fatty acid−P450BM3 complexes in the crystal is on the catalytic pathway, or whether it represents a 'dead-end' complex not normally populated under physiological conditions.
The existence of a hydrophobic pocket within the active site cavity, but relatively distant from the iron, also has implications for attempts to engineer the enzyme's activity towards novel target substrates.
It seems likely that small hydrophobic molecules could preferentially bind in the pocket between 4 phenylalanines 81 and 87, resulting in non-productive complexes. There have been many reports of changing the substrate specificity of P450BM3 by substitution of phenylalanine 87 by a smaller residue such as glycine, alanine or valine (e.g., 7; 28; 29; 30; 31; 32; 33; 34 ). Such substitutions would destroy the hydrophobic pocket, but would also increase the active site volume, which may result both in reduced coupling of NADPH consumption to product formation, due to less efficient exclusion of water from the active site, and in decreased regiospecificity of hydroxylation due to increased mobility of the substrate within the active site.
We have sought to investigate this issue by filling the hydrophobic pocket rather than destroying it.
This we have done by substitution of alanine 82 by the larger hydrophobic residues isoleucine, phenylalanine and tryptophan. Examination of the structure suggests that these substitutions should exclude progressively larger volumes of the hydrophobic pocket and, in the case of the aromatic substitutions, perhaps fill it altogether. The mutants A82F and A82W are observed to bind fatty acids orders of magnitude more tightly compared to the wild type, and to show substantially increased catalytic efficiency. In addition, these mutants are found to be effective catalysts of the oxidation of indole, resulting in formation of indigo, suggesting that they may exhibit generally improved activity towards small molecules.
RESULTS AND DISCUSSION
As shown in Figure 1A , in the crystal structures of substrate complexes of P450 BM3 the fatty acid chain binds in a hydrophobic pocket between phenylalanines 81 and 87, with the terminal methyl group in contact with Ala82. We have examined the substitution of Ala82 by a range of other residues. As shown in Figures 1B-D, this predicts that substitution by isoleucine, phenylalanine and tryptophan would be expected to fill progressively more of the pocket; the phenylalanine and tryptophan substitutions in particular would lead to a substantial predicted overlap with the end of the fatty acid chain, suggesting that they would prevent the binding of the fatty acid in the mode seen in the crystal structures. We therefore made and characterised the A82I, A82F and A82W mutants.
Fatty acid binding
Unlike the wild-type enzyme and the A82I mutant, the A82F and A82W mutants as purified were in a predominantly high spin state, suggesting tight binding of a substrate-like molecule, presumably an endogenous fatty acid from the E. coli host cells. This could not be removed by extensive dialysis or by gel filtration. However, treatment of the purified protein with a small excess of NADPH, followed by buffer exchange using extensive ultrafiltration to remove reaction products, resulted in conversion to a predominantly low spin form. Final preparations of the A82F and A82W mutants contained 20% and 25% high spin haem respectively.
In line with these qualitative observations, marked differences in fatty acid binding were observed between the wild-type enzyme and the A82I mutant on the one hand, and the A82F and A82W mutants on the other ( Figure 2 , ) for accurate determination by stopped-flow for either the wild-type or the A82F mutant.
In the case of palmitate, both wild-type and the mutant enzymes bound the substrate tightly and with substantial conversion to high spin haem (Table 1) , but noticeable differences were again observed between wild-type and A82I on the one hand, and the A82F and A82W mutants on the other. Palmitate binding to A82F and A82W was too tight to determine by this method (K d <0.1 μM) and was accompanied by complete conversion to high spin haem; in comparison wild-type and A82I gave between 85% and 90% high spin. The evidence that the endogenous fatty acid bound to the A82F enzyme as isolated is palmitate (see below) suggests that this substrate has a dissociation constant orders of magnitude below 0.1 μM, since it cannot be removed by dialysis. These data thus demonstrate that replacing Ala82 by larger, rigid sidechains leads to a marked increase in the affinity of the enzyme for fatty acids and also in the degree of conversion from low spin to high spin iron. By contrast, the substitution with the larger but more flexible isoleucine sidechain has essentially no effect. The products formed from the actions of the wild-type and mutant enzymes on laurate were identified by NMR spectroscopy; all of the mutants gave a mixture of (ω-1), (ω-2) and (ω-3) products, with only small differences in product distribution. A82F and A82I appeared to favour (ω-2) hydroxylation compared to wild-type, whilst A82W gave a slightly higher proportion of (ω-1) hydroxylated product ( Figure 3 ).
The A82W mutant exhibited relatively poor coupling of NADPH consumption to product formation, as demonstrated by the significant amount of unmetabolised laurate remaining in the reaction mixture ( Figure 3 ). Comparison of integrated peak areas allowed an estimate of approximately 45% coupling, whereas the other mutants gave much higher coupling efficiencies, estimated to be >90% in all cases. A82W was also notably less stable than the other mutants, being inactivated after an average of ~1000 turnovers per enzyme molecule. In view of the relatively poor coupling, this mutant may be inactivated by generation of reactive oxygen species such as peroxide; addition of catalase to the reactions did indeed increase the lifetime of the protein, although it did not afford complete protection of activity, suggesting that that A82W may be inactivated by active oxygen species generated at the iron before they can diffuse out of the active site.
Both the A82F and the A82W mutants showed significantly higher rates of NADPH consumption in the absence of substrate than did the wild-type or A82I enzymes (wild-type 0.14 s ); this is most likely to reflect the fact that, as noted above, these two mutants exist to a significant extent in the high-spin state in the absence of substrate.
Crystal structure of the fatty acid complex of P450BM3 A82F
In order to provide structural explanations for the marked differences in properties of the A82F and A82W mutants as compared to the wild-type enzyme, we determined the crystal structure of the haem domain of P450BM3 A82F. To date all crystallographic studies of P450BM3 have involved the haem domain of the enzyme rather than the intact enzyme, in which the flexibility of the two domains may inhibit crystallisation. We therefore expressed and purified the haem domain of the A82F mutant. As with the full-length protein, the A82F haem domain was isolated in a high spin form, suggesting again that a substrate-like molecule was bound; this could not be removed either by gel filtration or extensive dialysis (nor, in the absence of the reductase domain, by NADPH-supported catalytic turnover). Its identity was established by extracting a protein sample with dichloromethane, and analysis of the resultant solution by liquid chromatography-mass spectroscopy. The dominant component was identified as palmitic acid, with m/z = 255 and an identical retention time to an authentic standard; spiking the sample with authentic standard confirmed the identification. The presence of this fatty acid in the active site of A82F is unsurprising; as described above, palmitate binds extremely tightly to the full-length protein, and it has been identified as one of the three major fatty acids in the E. coli host cells. 37 Since the palmitate could not be removed, we crystallized the substrate complex of the haem domain using conditions similar to those previously reported. 16 Crystals were obtained in the P2 1 2 1 2 1 space group, and diffracted to 2.8Å resolution; in contrast to previous P450BM3 crystals, six chains were identified in the asymmetric unit. The structure was solved by molecular replacement, using the wildtype N-palmitoylglycine-bound structure (PDB 1JPZ) as a search model. Strong electron density was observed in the active site indicating the presence of bound fatty acid, and the structure was therefore refined with palmitate modelled in this position; the extent of the electron density was entirely consistent with the identification of the bound fatty acid as palmitate. The final model shows well-defined electron density for both the substrate and active site residues, including the phenylalanine side-chain at position 82.
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As can be seen in Figure 4A , the structure of the A82F mutant is very similar to that of the wildtype haem domain complexed with N-palmitoylglycine (PDB 1JPZ), and also to the palmitoleic acid complex (PDB 1FAG). The six chains in the unit cell all adopt essentially the same conformation, with
pairwise RMSD values between 0.49 and 0.83Å; the differences between them are confined mainly to loop regions and surface side chains, particularly to regions which are known to move on substrate binding, including the A helix, the β1 region and the F-G loop. There are however some noticeable differences in the binding of the substrate between the different chains in the crystal; these are discussed below.
The replacement of the small aliphatic side chain of A82 with the bulky aromatic side chain of phenylalanine in the mutant is readily accommodated with minimal changes to the protein structure compared to the two reported substrate complexes of the wild-type enzyme (RMSD < 0.74Å; Figure 4A ).
The ring of Phe82 fits between Phe81 and Phe87, and as predicted fills the hydrophobic pocket into which the fatty acid terminus binds in the wild-type structures ( Figure 4B ). This changes the shape of the substrate binding channel and reduces its overall length, forcing the substrate to adopt a different binding position, with the carboxylate group closer to the protein surface ( Figure 4C ). This apparently results in disruption of a hydrogen bond normally formed between the substrate carboxylate group and tyrosine 51.
Perhaps as a result of this, there are distinct differences in the binding position of the substrate between the six chains in the unit cell. This is in sharp contrast to the wild type structures, where the four chains in 1FAG and the two chains in 1JPZ each exhibit almost identical substrate binding modes. In A82F, the greatest difference in substrate binding position is between chains E and F, with a 2.5Å shift in the location of the carboxylate group between these two; the carboxylate is also between 2 and 4Å closer to the surface than is that of palmitoleic acid in the wild type complex. The considerable conformational flexibility of the sidechain of arginine 47 appears to help compensate for the repositioning of the carboxylate group between the various structures.
The 'filling in' of the hydrophobic pocket in the substrate binding channel by the A82F mutation results in a significant displacement of the fatty acid (ω-1) to (ω-3) carbons, which are the sites of metabolism, from their positions in the wild-type structures. The terminal methyl group of the substrate now points towards the side-chain of E267, some 4-6Å (depending on which chain is compared) away from its location adjacent to A82 in the wild type structure ( Figure 4C ). The key amino-acid residues in the binding site adopt essentially identical positions to those in the N-palmitoylglycine complex of the wild-type enzyme ( Figure 4C ). Notwithstanding the fact that the binding position of the substrate has changed, there is virtually no change in the regiospecificity of hydroxylation.
In the structure of the complex of the wild-type enzyme with N-palmitoyl-glycine ( 1JPZ 15 ), there is no water molecule coordinated to the iron (consistent with a high-spin complex), but there is an ordered water molecule positioned close to the iron and hydrogen bonded to A264 and T268. In the palmitoleic acid complex ( 1FAG 14 ), there are no water molecules in the PDB file, but a similarly located water molecule is seen in the electron density map for two of the four chains. This water molecule was identified by Haines et al. 15 as potentially crucial to the mechanism of proton transfer in P450BM3.
However, in the crystal structure of the palmitate complex of the A82F mutant there is electron density corresponding to this water molecule only in one of the six chains (chain D) ( Figure 4B and Supplementary Material). It is not clear why this should be so, since there is space for this water in the structure and the potentially hydrogen bonding residues are in the same place; it may be that the altered position of the terminal methyl group of the substrate makes this location more hydrophobic and thus water binding weaker. In any case, the absence of this water in the structure of the A82F mutant, which has a greater catalytic efficiency than the wild-type enzyme, raises questions about the mechanistic importance of a tightly bound water molecule near the iron. There is no doubt that it is essential for a water molecule to have access to this region of the active site close to the haem, and probably to be oriented by hydrogen-bonding to T268 38 , in order to participate in essential proton transfers, but it may not be necessary for it to be tightly bound in the oxidised form of the complex. P450BM3 is there unambiguous evidence that the crystals are catalytically active; widespread attempts to reduce the enzyme in the crystal have met with failure due to crystal cracking. However, since very similar structures of the enzyme-substrate complex are obtained for different substrates, for wild-type and mutant enzyme and in different space groups, it seems likely that these structures do represent relevant complexes. Thus it appears that, at some point in the catalytic cycle after the initial substrate binding, both wild-type and A82F P450BM3 must rearrange to conformations where the fatty acid substrate binds closer to the iron. Indeed previous work in our laboratory using paramagnetic relaxation experiments has suggested that substrates may move by as much as 6Å on reduction of the iron centre in the wild type protein. 40 The very similar product distributions in wild-type and A82F suggest that in this 'rearranged' conformation the substrate has a similar orientation in both wild-type and mutant complexes.
MacDermott et al. 25; 26; 27 have linked this requirement for a movement of the substrate into a 'catalytic' position to the equilibrium between low-spin and high-spin states of the complex, corresponding to six-coordinate (with an axial water ligand) and five-coordinate states of the haem iron.
Noting the fact that the low-spin -high-spin equilibrium is clearly temperature dependent in the wildtype enzyme, 26 they have suggested that the crystal structure of the N-palmitoyl-glycine complex, in which the substrate is bound in a 'distantly bound' position, corresponds to a low-spin state. As discussed above, in this complex there is a water molecule very close to the iron; 15 however the distance and angle between the water and the iron, along with the lack of any bonding electron density between them, are more consistent with the original assignment of the crystal structure as a high spin complex. MacDermott et al. 26; 27 suggest that at room temperature, where the complex is in the high-spin state and where catalytic activity is observed, the substrate has moved close to the iron. It is clear from the available structures that the aromatic ring of phenylalanine 87 appears to form a 'barrier' between the substrate in its 'distantly bound' position and the haem iron, and they propose that rotation of this ring is a key feature of the room temperature high-spin complex. 26; 27 In the light of this evidence for a temperature dependence of the low-spin -high-spin equilibrium and perhaps of the mode of substrate binding, we examined the UV/visible spectra of the palmitate complexes of the wild-type and mutant enzymes as a function of temperature between 4°C and 30°C ( Figure 5 ). The wild-type enzyme and the A82I mutant showed significant shifts to low-spin as the temperature was decreased, reaching an estimated 50% low-spin at 4°C for wild-type and 70% low-spin for A82I; however, in marked contrast there was no significant temperature dependence of the spectra for the A82F or A82W mutants, which remained completely high-spin at all temperatures examined. Taken together with the absence of a water molecule near the haem iron in the crystal structure, this strongly suggests that the palmitate complex of the A82F mutant is high-spin both in the crystal and in solution, and hence that the movement of the substrate into the 'catalytic' position is not coupled to the spin-state change; rather, a complete spin-state change can occur with the substrate in the 'distantly bound' position.
Structural origin of the tighter fatty acid binding
Experimentally we observe that fatty acids bind ~1000-fold more tightly to A82F than to the wild-type enzyme. However, the crystal structure of the palmitate complex offers no clear-cut explanation for this.
Indeed the position of the fatty acid appears less ordered than in the wild-type, presumably due to disruption of the hydrogen bond normally formed between the carboxylate and tyrosine 51, and this would be expected to result in weaker binding. Substitution of alanine 82 with the larger phenylalanine residue is likely to exclude water more efficiently from the complex, resulting in somewhat tighter binding due to hydrophobic effects, but it seems unlikely that this effect would be sufficient to explain the magnitude of the observed decrease in K d ; experiments using camphor derivatives designed to fill in 'holes' in the protein-substrate complex of P450cam resulted in much more modest increases in binding affinity.
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Since comparison of the substrate-bound structures provides no clear-cut explanation for the tighter binding to the A82F mutant, we need to consider in more detail the complete substrate binding process, and in particular the conformational change which occurs on substrate binding to wild-type P450BM3 14; 15 . Examination of the crystal structure of the substrate-free wild-type enzyme shows that alanine 82 is surrounded closely by phenylalanines 81 and 87 and isoleucine 263, such that there appears to be insufficient space to tolerate the substitution to phenylalanine (Figure 6 ). In the structure of the substrate complexes of the wild-type enzyme, the alkyl chain of the fatty acid displaces the side chains of isoleucine 263 and leucine 437, rotating them towards the F and G helices, and directly resulting in the repacking and displacement of this structural unit; the F helix is displaced about half a turn along its length, and by about two-thirds of its width laterally, between the two conformations. As noted above, the structure of the palmitate complex of the A82F mutant is very similar to that of the substrate complexes of the wild-type enzyme, and this is specifically true of this region of the structure and of Ile263. Examination of these structures suggests that the bulky side-chain of phenylalanine 82 itself would induce the same conformational change in isoleucine 263 (and hence in the F and G helices) in the absence of the substrate (Figure 6 ). The structural evidence thus indicates that, in the absence of substrate, P450BM3 A82F would adopt a conformation closely resembling the substrate-bound form (as observed for the A264E mutant 16 ). The substantial increase in binding affinity for fatty acids observed as a result of the substitution of Ala82 by phenylalanine would thus arise not from any change in interactions between the substrate and the enzyme as a result of the mutation, but rather from a shift in the conformational equilibrium in the free enzyme. By contrast, examination of the structure indicates that substitution of alanine 82 by isoleucine can be accommodated in the substrate-free conformation and would not perturb the conformational equilibrium; this would be consistent with the observation that the A82I mutant resembles the wild-type in many of its properties.
The substrate binding process
Combining the information from the present work with that already available from structural, spectroscopic and simulation studies allows us to postulate a sequence of events for the early stages of the catalytic cycle of P450BM3. First, we suppose that the free enzyme exists in an equilibrium between two conformations, corresponding to the 'substrate-free' and 'substrate-bound' conformations. The substrate binds preferentially to the 'substrate-bound' conformation; the data for the A82F and A82W mutants suggest that this preference must be several hundred-fold, although there is insufficient information available to provide a precise value. In this initial complex, the substrate is 'distantly bound', with the (ω-1) to (ω-3) carbons 7-9Å from the iron. In spite of this, the spin state equilibrium is shifted over towards the high-spin state -almost completely in the case of palmitate binding. This spin state shift is attributed to displacement of the water molecule from the sixth coordination position of the iron. The substrate itself is clearly too far from the iron to displace the water directly; however, the bound substrate makes contact with the sidechain of Phe87, leading to a reorientation of this sidechain 14; 15 which would in turn displace the water. There is space for the displaced water to remain within the active site, where it is likely to play a role in proton transfers, but from the structure of the A82F complex it appears that tight 13 binding of the displaced water is not essential. If the low-spin -high-spin transition arises from the rotation of Phe87, what is it that prevents this from occurring in the absence of substrate? In the 'substrate-free' conformation of the enzyme, Leu437 extends into the active site and approaches Phe87 quite closely; its two methyl groups appear to lock the ring of Phe87 in the 'vertical' position, preventing it from displacing water, and keeping the iron low-spin. Substrate binding and the conversion to the 'substrate bound' conformation displaces Leu437 significantly away from Phe87, such that the ring can now rotate and displace the water ligand from the iron. In the A82F and A82W mutants, the substitution itself leads to displacement of Ile263 and hence Leu437, and allows rotation of Phe87; as a result, for both these mutants there is a significantly larger proportion of high-spin iron in the absence of substrate (20-25%), together with a greater 'leak rate' of NADPH consumption in the absence of substrate.
The next step in the catalytic cycle is the essential movement of the substrate into a position closer to the iron, appropriate for hydroxylation, and again Phe87 appears to play a key role. Examination of the structure suggests that this residue forms a 'barrier' to this movement, and support for this comes from studies of isotope effects on the hydroxylation of small substrates by wild-type P450BM3 and the F87A mutant. 42 Molecular dynamics simulations provide evidence for the coupling of the movement of the substrate and the movement of the sidechain of Phe87. 27 This central role for Phe87 is consistent with a number of reports of substantial effects of mutation of this residue on substrate specificity (e.g. 28; 31; 32; 34; 43 ). Further work aimed at providing support for this postulated sequence of events is in progress.
Oxidation of indole by A82 mutants
Unlike the wild type enzyme or the A82I mutant, cells expressing P450BM3 A82F or P450BM3 A82W
were observed to produce an insoluble blue dye during normal growth. This has been previously observed with certain human P450 isoforms, notably CYP2A6 44; 45 and with the F87V mutant of for A82W) and the V max values higher, by a factor of 6, for A82F and A82W than for the wild-type; in addition, for these mutants the Hill coefficient is not significantly different from one (Table 2 ). Little increase in the NADPH consumption rate over that observed in the absence of substrate was observed at low indole concentrations, suggesting at most a modest contribution to the turnover rates by the very tight indole binding site observed by optical titration.
The coupling of product formation to NADPH consumption in the hydroxylation of indole was determined by measuring the formation of oxindole and indigo in reaction mixtures containing 8 mM indole and 200 μM NADPH; by ignoring the small amounts of isatin and indirubin formed, this will slightly underestimate the degree of coupling. As shown in Table 4 , very little product was generated by wild-type enzyme or the A82I mutant, and the coupling was very poor. The substitution of Ala82 by phenylalanine or tryptophan, on the other hand, led to marked increases in the coupling of product formation to NADPH consumption, and to a 170-fold increase in the rate of product formation. Taken together with the ≥25-fold increase in k cat /K M values estimated from the measurements of NADPH turnover, it is clear that the A82F and A82W substitutions lead to a substantial increase in the efficiency of indole hydroxylation by the enzyme.
CONCLUSIONS
Cytochrome P450BM3 is well-known to catalyse the hydroxylation of C12-C16 saturated fatty acids at the (ω-1), (ω-2) and (ω-3) positions. Nonetheless, the A82F and A82W mutants, in which this pocket has been filled with large rigid sidechains, showed a remarkable increase in affinity for fatty acids -to the extent that endogenous palmitate could not be removed by extensive dialysis -and in catalytic efficiency. It is unusual for a simple single-site substitution to lead to such a marked (~800-fold) increase in substrate affinity, but detailed comparison of the mutant and wild-type complexes did not reveal any differences in the enzyme-substrate interactions which are likely to account for this. The most likely explanation is that the substitution of the large sidechains at position 82 favours the 'substrate-bound' conformation, seen in the complexes with palmitoleate and N-palmitoyl-glycine and in the substrate-free A264E mutant, over the 'substrate-free' conformation, due to interactions of Phe82 or Trp82 with Ile263, leading in turn to movements of the F and G helices. As discussed by Joyce et al., 16 the free enzyme may exist in an equilibrium between these two conformations. By changing the position of this equilibrium in the absence of substrate, the mutations will decrease the proportion of the binding energy used up in shifting the equilibrium on substrate binding, leading to a net increase in affinity.
The observation of the formation of a blue pigment by cells expressing the A82F or A82W mutants of P450BM3 was the first indication that these mutants might be able efficiently to hydroxylate indole, with the formation of indigo, and this was unambiguously confirmed by studies of the isolated enzymes. The data suggest that, whilst both wild-type and A82I can bind indole, albeit weakly, it adopts a predominantly unproductive binding mode in the active sites of these proteins, since the amount of product formed is so low. It is possible that a significant proportion of the indole bound to these enzymes is located in the hydrophobic pocket bordered by Phe81, Phe87 and residue 82. In the mutants in which this pocket is filled by a larger sidechain at position 82, the efficiency of hydroxylation of indole is markedly increased, due both to increased k cat /K M values and to increased coupling between NADPH consumption and product formation. The evidence suggests that indole binding to P450BM3 is complicated, involving the binding of several indole molecules in catalytically productive, nonproductive and inhibitory positions; there is other evidence for the simultaneous binding of more than one substrate molecule to P450BM3 and its mutants. 49; 50 Notwithstanding these complications, the A82F and A82W mutants are clearly much more effective catalysts of indole hydroxylation than is the wildtype enzyme. There are two possible contributions to this improved catalytic efficiency. First, the substitution will lead to the removal of the potential non-productive binding site in the hydrophobic pocket; simple docking calculations (Figure 8 ) do indeed suggest that the preferred binding site for indole in the wild-type enzyme is the hydrophobic pocket, while in the A82F mutant it prefers to bind much closer to the haem, with the 2-and 3-positions closest to the iron, in position for hydroxylation.
Secondly, if, as suggested above, the mutation leads to a shift in the conformational equilibrium of the enzyme, this will increase the affinity for indole and in addition, with its effect on the environment of Phe87, will promote conversion to the high-spin state and hence the rate of electron transfer. Whichever is the more important contribution, the present results suggest that these mutants are not only very efficient fatty acid hydroxylases but also efficient hydroxylases of small hydrophobic molecules and hence may be useful biocatalysts in organic synthesis 51; 52 and perhaps in the biodegradation of polycyclic aromatic hydrocarbons.
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MATERIALS AND METHODS
Materials
The QuikChange XL mutagenesis kit was obtained from Stratagene, UK, and oligonucleotide primers 
Site-directed Mutagenesis
Wild-type and mutant proteins were expressed using the plasmid pGLWBM3, encoding full-length All mutant genes were fully sequenced to confirm the absence of any undesired mutations.
Protein expression and purification
Protein was expressed and purified using a modification of methods previously described; 28 the fulllength protein and the haem domain were purified in essentially the same way. Briefly, Escherichia coli JM109 cells harbouring pGLWBM3 were grown in 2×YT medium containing 100 μg/ml ampicillin at 30ºC for 6-8 hours to mid-log phase. The growth medium was supplemented by the addition of 0.5 mM 
a modification of the standard Michaelis-Menten equation which allows for a non-zero reaction rate at zero substrate concentration due to uncoupling reactions. V 0 is the rate of NADPH consumption in the absence of substrate, and ΔV max the maximal increase in rate at saturating substrate concentrations, such that the final maximal observed rate is equal to (V o + ΔV max ). For substrates that showed evidence of cooperativity, a similarly modified version of the Hill equation was used to estimate maximal rates, the substrate concentration giving 50% of the maximal rate, S 0.5 , and the Hill coefficient, n H . In view of the sub-stoichiometric incorporation of haem in some of the mutants, all catalytic rates were normalised to the haem content measured by CO-difference spectroscopy.
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Analysis of reaction products
The products of fatty acid hydroxylation were analysed by NMR using Bruker AMX500 and AMX600
instruments as described previously. 55 Reactions were carried out in and were initiated by the addition of NADPH. The absorbance at 340 nm was monitored to ensure the reactions reached completion; NADPH consumption rates in 2 H 2 O were found to be approximately 90% of those in water. Reaction mixtures were transferred to NMR tubes and the 1 H-NMR spectra measured directly.
The analysis of the products of indole hydroxylation was carried out separately for the soluble and insoluble products. HPLC analysis of the water-soluble products of the reactions of indole with P450BM3 was carried out as described 45 using an Agilent 1100 series instrument equipped with diodearray UV/Visible and fluorescence detection, and a Zorbax Reverse Phase SB C-18 4.6 × 250 mm column (5 μm particle size). All products were identified by demonstration of identical retention volumes to authentic standards, and quantitated by comparison of UV/Visible peak area integrations to known concentrations of authentic standards. The insoluble products were analysed by thin layer chromatography as described 46 and products identified by comparison to authentic standards of indigo and indirubin. In addition, the insoluble products from a 1ml reaction containing 1 μM P450BM3, 8 mM indole and 300 μM NADPH in 50 mM potassium phosphate, pH 8 were redissolved in 600 μl 2 H 6 -DMSO and the 1 H-NMR spectra were recorded.
Crystallography
The A82F haem domain was crystallised by the sitting drop method at 4°C. Sitting drops were prepared by adding 2.5 μl of precipitant mixture to 2.5 μl of 6 mg/ml haem domain; crystals were obtained by using a precipitant mixture of 140 mM MgCl 2 , 25% polyethylene glycol 2000MME and 100 mM MES, pH 5.0. Crystals were immersed in 10% polyethylene glycol 200 in mother liquor as a cryoprotectant before being mounted on a rayon loop and flash-cooled in liquid nitrogen. Diffraction data were collected at the European Synchrotron Radiation facility (Grenoble, France) on ID14-EH3 using an ADSC Q4R CCD detector. 180° data were collected at 100 K with 1° oscillations. Data were processed and scaled using MOSFLM 56 to conduct crystallographic refinement and COOT 61 was used for manual rebuilding and density interpretation. The data collection and final refinement parameters are given in Table 4 .
Docking calculations
The protein-ligand docking was performed using GOLD3.1.1 62 without any constraints. The template protein PDB files used were 1JPZ for the wild-type enzyme and 2UWH for the A82F mutant. The ligands were then docked into a sphere of radius 15 Å around the iron centre of haem.
Accession numbers
The refined coordinates and structure factors have been deposited with the protein databank (PDB 2UWH). 
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The triplet partially overlapping the 11-hydroxylaurate methyl resonance (δ=1.096, M=3, J=7.15Hz) is from an impurity in the NADPH, and is also present in control reactions containing no substrate. A1413T, C1416A BstBI V470-K472
The vector sequence was modified to incorporate a second BstBI site followed by a termination sequence after the end of the P450BM3 gene, to allow generation of P450 domain expression constructs for mutants of interest simply by BstBI digest followed by religation. The modification to the vector sequence was as follows: Electron density maps calculated using the omit procedure (2 cycles) in SFCHECK (CCP4)
showing the substrate binding site for all the six chains in the asymmetric unit. 
HPLC of water soluble products
The water-soluble products of indole hydroxylation by P450BM3 wild type (A) and the A82I (B), A82F (C), and A82W (D) mutants analysed using HPLC, measuring absorbance at 240 nm. The retention times of dioxindole (1), isatin (2), oxindole (3), indole (4), and indigo (5) are indicated.
